Humana Inc (HUM) concluded trading on Thursday at a closing price of $293.80, with 4.99 million shares of worth about $1.47 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -23.86% during that period and on January 23, 2025 the price saw a gain of about 3.12%. Currently the company’s common shares owned by public are about 120.41M shares, out of which, 120.14M shares are available for trading.
Stock saw a price change of 5.12% in past 5 days and over the past one month there was a price change of 24.61%. Year-to-date (YTD), HUM shares are showing a performance of 15.80% which decreased to -28.28% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $213.31 but also hit the highest price of $411.80 during that period. The average intraday trading volume for Humana Inc shares is 1.75 million. The stock is currently trading 9.10% above its 20-day simple moving average (SMA20), while that difference is up 6.71% for SMA50 and it goes to -7.44% lower than SMA200.
Humana Inc (NYSE: HUM) currently have 120.41M outstanding shares and institutions hold larger chunk of about 95.91% of that.
The stock has a current market capitalization of $35.38B and its 3Y-monthly beta is at 0.57. PE ratio of stock for trailing 12 months is 26.01, while it has posted earnings per share of $11.29 in the same period. Its PEG reads 10.37 while making debt-to-equity ratio of 0.74. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HUM, volatility over the week remained 4.66% while standing at 3.58% over the month.
Analysts are in expectations that Humana Inc (HUM) stock would likely to be making an EPS of -2.05 in the current quarter, while forecast for next quarter EPS is 6.92 and it is 17.34 for next year. For the current quarter EPS, analysts have given the company a lowest target -2.52 which is -1.1 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.11 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -38.14% while it is estimated to increase by 4.27% in next year. EPS is likely to shrink at an annualized rate of 2.51% for next 5-years, compared to annual growth of 10.46% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BofA Securities on November 06, 2024 offering a Neutral rating for the stock and assigned a target price range of between $247 and $308 to it. On October 08, 2024, Bernstein Upgrade their recommendations, while on October 07, 2024, TD Cowen Downgrade their ratings for the stock with a price target of $261. Stock get a Hold rating from Jefferies on October 07, 2024.
